TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the ...

The findings provide contemporary surgical benchmarks, which will become even more important as M-TEER trial data emerge.

Yet overall performance was good with both the ESC and High-STEACS strategies, leaving hospitals room to choose.

A study shows harm in short-term exposures and proposes a particulate threshold that could influence air quality alerts.

This reinforces the need for a CV assessment and surveillance before, during, and after the therapy, a researcher says.

Doctors say that identifying the right patients will be critical to the future of the field. Only time will tell, according to trialists.

Debates for and against intervention focused on that key window when cardiac damage has arrived, but not yet symptoms.

The meeting will feature sessions on AI in heart failure, advanced LVAD technologies, cardiac xenotransplantation, and more.

What to make of the results remains uncertain, but experts agree that greater vigilance in low-risk patients is warranted.

Across 21 European countries, higher GDP per capita was tied to better acute MI survival on a population level—not so for ...

Repeat screening for CAC progression could identify which patients are most at risk of deteriorations in cognitive health.

Mamas Mamas sits down with Alaide Chieffo and Thomas Lüscher to discuss the organization’s inaugural Summit and its ...